Literature DB >> 32263740

"Dark" carbon dots specifically "light-up" calcified zebrafish bones.

Shanghao Li1, Isaac Skromne, Zhili Peng, Julia Dallman, Abdulrahman O Al-Youbi, Abdulaziz S Bashammakh, Mohammad S El-Shahawi, Roger M Leblanc.   

Abstract

Because accidents, disease and aging compromise the structural and physiological functions of bones, the development of an in vivo bone imaging test is critical to identify, detect and diagnose bone related development and dysfunctions. Recent advances in fluorescence instrumentation offer a new alternative for traditional bone imaging methods. However, the development of new in vivo bone imaging fluorescence materials has significantly lagged behind. Here we show that carbon dot nanoparticles (C-dots) with low quantum yield ("dark") bind to calcified bone structures of live zebrafish larvae with high affinity and selectivity. Binding resulted in a strong enhancement of luminescence that was not observed in other tissues, including non-calcified endochondral elements. Retention of C-dots by bones was very stable, long lasting, and with no detectable toxicity. Furthermore, we found C-dots to be a suitable carrier to deliver fluorescein to bones. These observations support a novel and revolutionary use of C-dots as highly specific bioagents for bone imaging and diagnosis, and as bone-specific drug delivery vehicles.

Entities:  

Year:  2016        PMID: 32263740     DOI: 10.1039/c6tb02241c

Source DB:  PubMed          Journal:  J Mater Chem B        ISSN: 2050-750X            Impact factor:   6.331


  2 in total

1.  In vivo characterization of carbon dots-bone interactions: toward the development of bone-specific nanocarriers for drug delivery.

Authors:  Rachel DuMez; Esmail H Miyanji; Lesly Corado-Santiago; Bryle Barrameda; Yiqun Zhou; Sajini D Hettiarachchi; Roger M Leblanc; Isaac Skromne
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.419

2.  Optimized Doxorubicin Chemotherapy for Diffuse Large B-cell Lymphoma Exploits Nanocarrier Delivery to Transferrin Receptors.

Authors:  Artavazd Arumov; Piumi Y Liyanage; Roger M Leblanc; Jonathan H Schatz; Asaad Trabolsi; Evan R Roberts; Lingxiao Li; Braulio C L B Ferreira; Zhen Gao; Yuguang Ban; Austin D Newsam; Melissa W Taggart; Francisco Vega; Daniel Bilbao
Journal:  Cancer Res       Date:  2020-11-11       Impact factor: 13.312

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.